22 min
EPISODE #75 Cannabis 2.0 in Canada with Tyler Robson, CEO at The Valens Company The Cannabis Conversation | Medical Cannabis | CBD | Hemp
-
- Business
This week we’re joined by Tyler Robson, CEO at The Valens Company - biotech company and global leaders in the end-to-end production of cannabinoid-based products.
Together, we discuss the newest wave of cannabis legalisation and innovation in Canada - Cannabis 2.0. We explore novel extraction techniques, the power of extracts and derivatives, the newest products on the market, and opportunities for the future.
→ View full show notes and summary here: https://www.cannabis-conversation.com/blogs/episode75
About Tyler
Tyler Robson was appointed CEO of The Valens Company in May 2017 after previously serving as Chief Operating Officer for several years. He attended the University of Saskatchewan, graduating with a Bachelor of Arts & Sciences degree specializing in biology, before returning to Kelowna to pursue his passion for the cannabis industry by focusing on research and development, plant innovation, and life sciences. Tyler has significantly scaled operations and increased profitability at The Valens Company since taking on the role of CEO, leading to the Company’s ability to capture market share and lead the industry as a major player in the supply chain of leading Canadian and international brands.
Quotables
We believe in consistent dosing and consumer experiences 03:10
I have a really hard time believing [cannabis] flower [can be used for] medical [applications]. When you look at inhalation, it’s definitely not the cleanest way of ingestion and it’s inconsistent 04:35
Resources
Join Tyler on LinkedIn: https://www.linkedin.com/in/tyler-robso
The Valens Company Website: https://thevalenscompany.com/
Cannabis 2.0 report by Deloitte: https://www2.deloitte.com/content/dam/Deloitte/ca/Documents/c-and-ip/ca-en-consumer-nurturing-new-growth-en-aoda-may31.pdf
Please take a moment to review us on iTunes: https://podcasts.apple.com/gb/podcast/cannabis-conversation-european-perspective-on-emerging/id1454098889
This week we’re joined by Tyler Robson, CEO at The Valens Company - biotech company and global leaders in the end-to-end production of cannabinoid-based products.
Together, we discuss the newest wave of cannabis legalisation and innovation in Canada - Cannabis 2.0. We explore novel extraction techniques, the power of extracts and derivatives, the newest products on the market, and opportunities for the future.
→ View full show notes and summary here: https://www.cannabis-conversation.com/blogs/episode75
About Tyler
Tyler Robson was appointed CEO of The Valens Company in May 2017 after previously serving as Chief Operating Officer for several years. He attended the University of Saskatchewan, graduating with a Bachelor of Arts & Sciences degree specializing in biology, before returning to Kelowna to pursue his passion for the cannabis industry by focusing on research and development, plant innovation, and life sciences. Tyler has significantly scaled operations and increased profitability at The Valens Company since taking on the role of CEO, leading to the Company’s ability to capture market share and lead the industry as a major player in the supply chain of leading Canadian and international brands.
Quotables
We believe in consistent dosing and consumer experiences 03:10
I have a really hard time believing [cannabis] flower [can be used for] medical [applications]. When you look at inhalation, it’s definitely not the cleanest way of ingestion and it’s inconsistent 04:35
Resources
Join Tyler on LinkedIn: https://www.linkedin.com/in/tyler-robso
The Valens Company Website: https://thevalenscompany.com/
Cannabis 2.0 report by Deloitte: https://www2.deloitte.com/content/dam/Deloitte/ca/Documents/c-and-ip/ca-en-consumer-nurturing-new-growth-en-aoda-may31.pdf
Please take a moment to review us on iTunes: https://podcasts.apple.com/gb/podcast/cannabis-conversation-european-perspective-on-emerging/id1454098889
22 min